Ulrike Leiter

Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial

Ulrike Leiter, Rudolf Stadler, Cornelia Mauch et al. · The Lancet Oncology · 2016 · 684 citations

Surgical Oncology, Medicine, Surgical Pathology +7

Melanoma epidemiology and trends

Claus Garbe, Ulrike Leiter · Clinics in Dermatology · 2008 · 641 citations

Cancer Epidemiology, Medicine, Melanoma Epidemiology +8

Age and gender are significant independent predictors of survival in primary cutaneous melanoma

Konstantinos Lasithiotakis, Ulrike Leiter, Friedegund Meier et al. · Cancer · 2008 · 245 citations · Full text

Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node

Ulrike Leiter, Rudolf Stadler, Cornelia Mauch et al. · Journal of Clinical Oncology · 2019 · 236 citations

Incidence, Mortality, and Trends of Nonmelanoma Skin Cancer in Germany

Ulrike Leiter, Ulrike Keim, Thomas Eigentler et al. · Journal of Investigative Dermatology · 2017 · 225 citations

Nonmelanoma Skin Cancer, Cancer Epidemiology, Medicine +8